Skip to main content
. 2017 Dec 12;8:913. doi: 10.3389/fphar.2017.00913

FIGURE 4.

FIGURE 4

Schematic representation of the modulation of purinergic systems to block/decrease the overactivation of CB present in sympathetic-mediated diseases, as type 2 diabetes and essential hypertension.